Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID | D05RWD | ||||
| Former ID | DIB002984 | ||||
| Drug Name | Research programme: farnesoid X receptor agonists, Roche | ||||
| Synonyms | Farnesoid X receptor agonists (dyslipidemia/diabetes); FXR agonists (dyslipidemia/ diabetes), Roche; Farnesoid X receptor agonists (dyslipidemia/diabetes), Roche | ||||
| Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Investigative | [543895] | ||
| Company | Roche Holding AG | ||||
| Canonical SMILES | c1(c(cc2c(c1)nc(n2[C@H](C(=O)Nc1ccc(cc1F)C(=O)O)C1CCCCC<br />1)c1ccc(cc1)Cl)F)F | ||||
| Target and Pathway | |||||
| Target(s) | Bile acid receptor | Target Info | Agonist | [543895] | |
| KEGG Pathway | Bile secretion | ||||
| Pathway Interaction Database | RXR and RAR heterodimerization with other nuclear receptor | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
